Related Experiment Video

Updated: May 8, 2026

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools
07:01

Navigating the Mass Spectrometry-Based Proteomic Data Using Free Computational Tools

Published on: August 19, 2025

Key pathways and genes controlling the development and progression of clear cell renal cell carcinoma (ccRCC) based

Haipeng Huang1, Yanyan Tang, Wenwu He

  • 1Department of Urinary Surgery, The First Affiliated Hospital, Guangxi Medical University, 6th Shuangyong Road, Nanning, 530021, Guangxi, China.

International Urology and Nephrology
|August 15, 2013
PubMed
Abstract

Insights

This study identified 37 key gene pathways linked to clear-cell renal cell carcinoma (ccRCC) development using GSEA and meta-analysis. These findings offer insights into ccRCC pathogenesis and potential targeted therapies.

Area of Science:

  • Oncology
  • Genetics
  • Bioinformatics

Background:

  • Clear-cell renal cell carcinoma (ccRCC) is a prevalent adult cancer with incompletely understood origins.
  • Identifying key molecular drivers is crucial for advancing ccRCC treatment strategies.

Purpose of the Study:

  • To identify critical pathways and genes involved in ccRCC occurrence and progression.
  • To elucidate ccRCC pathogenesis at the gene and pathway levels.
  • To provide theoretical evidence for developing targeted ccRCC therapies.

Main Methods:

  • Utilized Gene Set Enrichment Analysis (GSEA) and meta-analysis (Meta) to screen for significant pathways and genes.
  • Employed the DAVID online tool to identify pathways associated with significant genes.
  • Focused on transcriptional level analysis for ccRCC progression.

Main Results:

  • Identified 37 consistent pathways and key genes associated with ccRCC.
  • These pathways are primarily involved in metabolism, organismal systems, cellular processes, and environmental information processing.
  • The analysis revealed significant molecular signatures related to ccRCC development.

Conclusions:

  • The identified gene pathways provide valuable insights into ccRCC development.
  • Further research is warranted to determine the specific biological functions of the identified genes.
  • These findings may pave the way for novel therapeutic interventions in ccRCC.

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane05:36

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

Related Concept Videos

Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...